Macular atrophy predicts vision in ranibizumab-treated exudative AMD patients
Progression and severity of macular atrophy are the main anatomical determinants of long-term visual outcomes in exudative age-related macular degeneration patients treated with ranibizumab, suggest SEVEN-UP study results.